CLINICAL_TRIALS
trial_result
· 2008-02-21
Clinical Trial Update: PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension [Phase 3]
Summary
Phase 3 PHIRST-1 trial evaluating tadalafil for pulmonary arterial hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED